Indegene and ConTIPI Medical Ltd Partner to Bring Innovative Disposable Non-surgical Device to Market to Help Women Suffering from Pelvic Organ Prolapse (POP) Font : A-A+
PRINCETON, N.J., March 03, 2021 (GLOBE NEWSWIRE) Indegene, a global enterprise healthtech solutions company and ConTIPI Medical Ltd, an innovator in the field of providing non-surgical and disposable solutions for women with various pelvic floor disfunctions, today announced a partnership to bring a new device to the market to help women suffering from Pelvic Organ Prolapse (POP). The US FDA states that POP occurs when the pelvic floors tissues and muscles can no longer support its organs. This causes a drop or prolapse of the pelvic organs from their normal position into the vagina and even outside the body. POP is prevalent in approximately 54 million American women over 20 years old
Philips Spotlights New Integrated Informatics and System Solutions to Drive Workflow Optimization and Advance Precision Diagnosis at ECR 2021 Font : A-A+
Expanded Philips Radiology Workflow Suite features new, AI-enabled solutions to streamline workflows across the entire imaging enterprise
Solutions integrate and automate workflow to help improve efficiency and clinical confidence to enable earlier and more definitive diagnosis
Philips portfolio of award-winning diagnostic systems and interventional solutions will be featured in a unique virtual ECR experience
Amsterdam, the Netherlands
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its participation in the European Congress of Radiology (ECR) virtual event, March 3-7, 2021, where the company will feature new and enhanced diagnostic and interventional solutions that further expand its Radiology Workflow Suite, connecting data, technology and people across the imaging ente
HCSD s Medication Assisted Treatment program providing critical bridge to addiction treatment and recovery during pandemic Font : A-A+
More than 1,400 patients treated by CODAC and HCSD staff LUDLOW, Mass. and CRANSTON, R.I., March 3, 2021 /PRNewswire-PRWeb/ Over the past year, COVID-19 has changed every facet of life and recent CDC data suggest it helped worsen the already overwhelming opioid epidemic. While addiction-related issues have spiked during the pandemic, the Hampden County Sheriff s Medication Assisted Treatment (MAT) program has helped hundreds of men and women battling substance use disorder. Through a partnership with CODAC Behavioral Healthcare, the largest non-profit, outpatient provider for opioid treatment in Rhode Island, the Hampden County MAT program pairs counseling and behavioral therapy along with access to all three FDA-approved addiction medications for treating substance use disorder: methadone, buprenorphine and naltrexone.
Shez Partovi to Succeed Jeroen Tas as Philips Chief Innovation & Strategy Officer Font : A-A+
Amsterdam, the Netherlands
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Shez Partovi will join Philips Executive Committee, effective from March 22, 2021, in order to succeed Jeroen Tas as Chief Innovation & Strategy Officer, effective from July 1, 2021. Mr. Partovi will report directly to CEO Frans van Houten and work closely with Mr. Tas to ensure a seamless transition. Mr. Partovi (Canadian, 1967) joins Philips from Amazon Web Services (AWS), where he served as Worldwide Head of Business Development for Healthcare, Life Sciences and Medical Devices. In that role, he was responsible for the global AWS go-to-market strategy, charting the path for customer cloud transformation, and the adoption of artificial intelligence and machine learning. Prior to joining AWS in 2018, Mr. Partovi spent 20 years at Dignity Health, the fif
Conformis, Inc. Announces Clearance in Australia for iTotal® PS, the Only Personalized, Posterior-Stabilized Total Knee Replacement System Font : A-A+
BILLERICA, Mass., March 01, 2021 (GLOBE NEWSWIRE) Conformis, Inc. (NASDAQ: CFMS) today announced the clearance of its patient-specific iTotal® PS total knee replacement system by the Therapeutic Goods Administration, which is part of the Australian Department of Health, and which authorizes the marketing of medical devices and other healthcare products in Australia. The iTotal® PS system, which launched in the United States in 2016, is designed to address the shortcomings of traditional, off-the-shelf knee replacements that are manufactured in limited sizes and shapes. iTotal® PS implants are specifically designed to restore the natural shape of each patients knee, and to avoid overhang, rotation, and sizing compromises associated with pain after surgery. Primary total knee implants are designed to either retain the pa